AntibodyTargeted-Drug Conjugates 2015

13-15 April 2015, Crowne Plaza Porto, Porto, Portugal

  • Increase font size
  • Default font size
  • Decrease font size

Poster Session

Posters will be on display for the entire meeting.

Poster 101
‘Assays for the selection and functional characterization of antibody drug conjugates at the National Research Council of Canada (NRCC)’
Maria Luz Jaramillo, Myriam Banville, Luc Meury, Normand Jolicoeur and Maureen O’Connor-McCourt (Human Health Therapeutics, NRC of Canada, Montreal, Quebec, Canada)

Poster 102
‘Preparation of antibody recognizing heteromers of dopamine D2 and serotonin 5-HT1A receptors using phage display technology’
Sylwia Lukasiewicz, Ewa Blasiak, Agata Stachowicz, Ewelina Fic and Marta Dziedzicka-Wasylewska (Jagiellonian University, Krakow, Poland)

Poster 103
‘Development and biological evaluation of photosensitizer-anti-HER2 conjugates for targeted photodynamic therapy of gastric cancer’
Barbara Korsak, Rudolf J. Schneider, Bruno Sarmento, Carla Oliveira and João P. C. Tomé (University of Aveiro, Aveiro, Portugal)

Poster 104
‘Multiple loading of drugs improves the activity of their targeted peptide conjugates’
Y. Gilad, E. Noy, H. Senderowitz, A. Albeck, M.A. Firer MA and G. Gellerman (Ariel University, Ariel, Israel)

Poster 105
‘Computational, drug release and biological evaluation of three new anti-cancer cyclic RGD peptide conjugates’
Y. Gilad, E. Noy, H. Senderowitz, A. Albeck, M.A. Firer MA and G. Gellerman (Ariel University, Ariel, Israel)

Poster 106
‘“Switch off/switch on” regulation of drug cytotoxicity by conjugation to a cell targeting peptide’
Y. Gilad, M.A.Firer, A. Rozovsky, E. Ragozin, B. Redko, A. Albeck and G. Gellerman (Ariel University, Ariel, Israel)

Poster 107
‘Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar’
Zhongyu Zhu, Ramakrishnan Boopathy, Jinyu Li, Ponraj Prabakaran, Simona Colantonio, Yang Feng, Yanping wang, Marzena A. Dyba and Dimiter S. Dimitrov (National Cancer Institute, NIH, Bethesda, Marymand, USA)

Poster 108
‘New platform for antibody developability and manufacturability assessment’
Christoph Freiberg1, Christopher Smith2, Sebastian Schlicker2, Willem Westra3, Maria Wendt1 and Hans Peter Fischer1 (1 Genedata AG, Basel, Switzerland; 2 Genedata Inc., Boston, Massachusetts, USA; 3 Genedata Inc., San Francisco, California, USA)

Poster 109
‘An integrated system for the design and evaluation of antibody drug conjugates’
Andreas Kaufmann1, Maria Wendt1, Peter Ernst1, Christopher Smith2, Carl Bruder1, Guido Cappuccilli1 and Hans Peter Fischer1 (1 Genedata AG, Basel, Switzerland; 2 Genedata Inc., Boston, Massachusetts, USA)

Poster 110
‘Synthesis, drug release and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety’
B. Redko, A. Albeck, M. Firer and G. Gellerman (Ariel University, Ariel, Israel)

 

ATDC 2015 Sponsors

  • ONdrugDelivery
  • Sutro Biopharma
  • ImmunoGen
  • NatureGeneTherapy.com
  • Synthon
  • NBE Therapeutics
  • Nascent Biologics
  • Pfizer Oncology
  • Catalent
  • ADC Review
  • DNAvaccine.com
  • LinXis
  • Aldevron
  • Biovest
  • Oncozine
  • Genentech

ATDC 2015 Downloads

ATDC 2015 Leaflet

ATDC 2015 Mailing List

Name
E-mail Address
What is 3+2-1?